Table 2.
Composite and individual outcomes in Azvudine group vs. matched controls.
| Outcome | Azvudine |
Controls |
|||
|---|---|---|---|---|---|
| n (%) | rate per 1000 person-days | n (%) | rate per 1000 person-days | Pa | |
| Composite outcome, n (%) | 17 (6.94) | 7.125 | 31 (12.65) | 16.004 | 0.018 |
| All-cause death, n (%) | 5 (2.04) | 1.934 | 9 (3.67) | 4.128 | 0.159 |
| Intensive care unit admission, n (%) | 2 (0.82) | 0.838 | 1 (0.41) | 0.516 | 0.911 |
| Initiation of invasive mechanical ventilation, n (%) | 2 (0.82) | 0.838 | 2 (0.82) | 1.033 | 0.728 |
| Non-invasive respiratory support, n (%) | 16 (6.53) | 6.706 | 26 (10.61) | 13.423 | 0.056 |
P value for log-rank test.